Ewa M. Urbańska

2.1k total citations
85 papers, 1.6k citations indexed

About

Ewa M. Urbańska is a scholar working on Biological Psychiatry, Psychiatry and Mental health and Behavioral Neuroscience. According to data from OpenAlex, Ewa M. Urbańska has authored 85 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Biological Psychiatry, 35 papers in Psychiatry and Mental health and 32 papers in Behavioral Neuroscience. Recurrent topics in Ewa M. Urbańska's work include Tryptophan and brain disorders (55 papers), Stress Responses and Cortisol (32 papers) and Neuroscience and Neuropharmacology Research (25 papers). Ewa M. Urbańska is often cited by papers focused on Tryptophan and brain disorders (55 papers), Stress Responses and Cortisol (32 papers) and Neuroscience and Neuropharmacology Research (25 papers). Ewa M. Urbańska collaborates with scholars based in Poland, Sweden and United States. Ewa M. Urbańska's co-authors include Waldemar A. Turski, Tomasz Kocki, Marian Wielosz, Piotr Luchowski, Elżbieta Luchowska, Aleksandra Ostapiuk, Zdzisław Kleinrok, Björn Owe‐Larsson, Tomasz Saran and Chrysanthy Ikonomidou and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Brain Research.

In The Last Decade

Ewa M. Urbańska

81 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ewa M. Urbańska Poland 24 937 547 513 410 385 85 1.6k
Lian Yuan Cao China 19 915 1.0× 482 0.9× 522 1.0× 336 0.8× 231 0.6× 22 1.6k
Harry Steinbusch Netherlands 19 644 0.7× 561 1.0× 229 0.4× 448 1.1× 421 1.1× 31 1.9k
Ewa Obuchowicz Poland 21 690 0.7× 615 1.1× 206 0.4× 461 1.1× 382 1.0× 79 1.7k
Tomasz Kocki Poland 24 1.0k 1.1× 590 1.1× 344 0.7× 124 0.3× 399 1.0× 87 1.5k
Korrapati V. Sathyasaikumar United States 18 975 1.0× 549 1.0× 392 0.8× 259 0.6× 424 1.1× 27 1.4k
Roger B. Varela Brazil 24 430 0.5× 135 0.2× 522 1.0× 284 0.7× 417 1.1× 55 1.4k
David Dao United States 12 304 0.3× 287 0.5× 157 0.3× 409 1.0× 494 1.3× 27 1.5k
Funda Orhan Sweden 12 657 0.7× 379 0.7× 239 0.5× 106 0.3× 239 0.6× 23 1.2k
Zsolt Kis Hungary 22 336 0.4× 268 0.5× 126 0.2× 334 0.8× 208 0.5× 48 1.1k
Jolanta Parada-Turska Poland 22 348 0.4× 204 0.4× 205 0.4× 331 0.8× 458 1.2× 55 1.3k

Countries citing papers authored by Ewa M. Urbańska

Since Specialization
Citations

This map shows the geographic impact of Ewa M. Urbańska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewa M. Urbańska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewa M. Urbańska more than expected).

Fields of papers citing papers by Ewa M. Urbańska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ewa M. Urbańska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewa M. Urbańska. The network helps show where Ewa M. Urbańska may publish in the future.

Co-authorship network of co-authors of Ewa M. Urbańska

This figure shows the co-authorship network connecting the top 25 collaborators of Ewa M. Urbańska. A scholar is included among the top collaborators of Ewa M. Urbańska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ewa M. Urbańska. Ewa M. Urbańska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Urbańska, Ewa M., et al.. (2025). Microbiota-Derived Tryptophan Metabolite Indole-3-Propionic Acid-Emerging Role in Neuroprotection. Molecules. 30(17). 3628–3628. 8 indexed citations
2.
Urbańska, Ewa M., et al.. (2024). Kynurenine Pathway after Kidney Transplantation: Friend or Foe?. International Journal of Molecular Sciences. 25(18). 9940–9940. 2 indexed citations
3.
Dobrowolski, Piotr, Mirosława Chwil, Ilona Sadok, et al.. (2024). The GPR39 Receptor Plays an Important Role in the Pathogenesis of Overactive Bladder and Corticosterone-Induced Depression. International Journal of Molecular Sciences. 25(23). 12630–12630.
4.
Urbańska, Ewa M., et al.. (2024). Novel Activity of Oral Hypoglycemic Agents Linked with Decreased Formation of Tryptophan Metabolite, Kynurenic Acid. Life. 14(1). 127–127. 5 indexed citations
5.
Urbańska, Ewa M., et al.. (2024). Microbiota, Tryptophan and Aryl Hydrocarbon Receptors as the Target Triad in Parkinson’s Disease—A Narrative Review. International Journal of Molecular Sciences. 25(5). 2915–2915. 16 indexed citations
6.
Urbańska, Ewa M., et al.. (2024). Memantine and the Kynurenine Pathway in the Brain: Selective Targeting of Kynurenic Acid in the Rat Cerebral Cortex. Cells. 13(17). 1424–1424. 2 indexed citations
7.
Kocki, Tomasz, et al.. (2023). Effects of Fenofibrate and Gemfibrozil on Kynurenic Acid Production in Rat Kidneys In Vitro: Old Drugs, New Properties. Life. 13(11). 2154–2154. 2 indexed citations
8.
Urbańska, Ewa M., et al.. (2023). New Perspective on Anorexia Nervosa: Tryptophan-Kynurenine Pathway Hypothesis. Nutrients. 15(4). 1030–1030. 3 indexed citations
9.
Urbańska, Ewa M., et al.. (2023). Kynurenine Pathway in Diabetes Mellitus—Novel Pharmacological Target?. Cells. 12(3). 460–460. 61 indexed citations
10.
Dudzińska, Ewa, Tomasz Kocki, Paulina Gil-Kulik, et al.. (2021). Fractalkine, sICAM-1 and Kynurenine Pathway in Restrictive Anorexia Nervosa–Exploratory Study. Nutrients. 13(2). 339–339. 4 indexed citations
11.
Ostapiuk, Aleksandra & Ewa M. Urbańska. (2021). Kynurenic acid in neurodegenerative disorders—unique neuroprotection or double‐edged sword?. CNS Neuroscience & Therapeutics. 28(1). 19–35. 81 indexed citations
12.
Gil-Kulik, Paulina, et al.. (2019). Losartan Reverses Hippocampal Increase of Kynurenic Acid in Type 1 Diabetic Rats: A Novel Procognitive Aspect of Sartan Action. Journal of Diabetes Research. 2019. 1–8. 5 indexed citations
15.
Kocki, Tomasz, et al.. (2011). New insight into the antidepressants action: modulation of kynurenine pathway by increasing the kynurenic acid/3-hydroxykynurenine ratio. Journal of Neural Transmission. 119(2). 235–243. 55 indexed citations
16.
Luchowska, Elżbieta, et al.. (2009). Clenbuterol enhances the production of kynurenic acid in brain cortical slices and glial cultures.. PubMed. 60(4). 574–7. 2 indexed citations
17.
Wielosz, Marian, et al.. (2008). Hyperglycemia enhances the inhibitory effect of mitochondrial toxins and D,L-homocysteine on the brain production of kynurenic acid.. PubMed. 59(3). 268–73. 13 indexed citations
18.
Kocki, Tomasz, Tomasz Saran, Sándor Borbély, et al.. (2005). Effect of pesticides on kynurenic acid production in rat brain slices.. PubMed. 12(2). 177–9. 8 indexed citations
19.
Urbańska, Ewa M., et al.. (2002). Effect of adenosine receptor agonists on neurodegenerative and convulsive activity of mitochondrial toxin, 3-nitropropionic acid.. PubMed. 53(1). 69–71. 2 indexed citations
20.
Urbańska, Ewa M., Paolo Guidetti, Edward D. Bird, et al.. (1995). Dysfunction of brain kynurenic acid metabolism in Huntington's disease: focus on kynurenine aminotransferases. Journal of the Neurological Sciences. 130(1). 39–47. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026